Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro A Castellarin

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
JAMA Ophthalmology|April 28, 2017
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and RanibizumabSusan B Bressler, Danni Liu, Adam R Glassman, et al.
Retina (Philadelphia, Pa.)|September 30, 2016
TREATMENT OF VITREOMACULAR TRACTION WITH INTRAVITREAL PERFLUOROPROPANE (C3F8) INJECTIONNathan C Steinle, Dilsher S Dhoot, Carlos Quezada Ruiz, et al.
Retina (Philadelphia, Pa.)|February 2, 2011
Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusionSarah M Risard, Dante J Pieramici, Melvin D Rabena, et al.
The British Journal of Ophthalmology|July 9, 2014
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMDRobert L Avery, Alessandro A Castellarin, Nathan C Steinle, et al.
Retina (Philadelphia, Pa.)|January 21, 2017
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMABRobert L Avery, Alessandro A Castellarin, Nathan C Steinle, et al.
Ophthalmology|May 28, 2013
Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trialsMaureen G Maguire, Ebenezer Daniel, Ankoor R Shah, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
JAMA Ophthalmology|April 28, 2017
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and RanibizumabSusan B Bressler, Danni Liu, Adam R Glassman, et al.
Retina (Philadelphia, Pa.)|September 30, 2016
TREATMENT OF VITREOMACULAR TRACTION WITH INTRAVITREAL PERFLUOROPROPANE (C3F8) INJECTIONNathan C Steinle, Dilsher S Dhoot, Carlos Quezada Ruiz, et al.
Retina (Philadelphia, Pa.)|February 2, 2011
Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusionSarah M Risard, Dante J Pieramici, Melvin D Rabena, et al.
The British Journal of Ophthalmology|July 9, 2014
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMDRobert L Avery, Alessandro A Castellarin, Nathan C Steinle, et al.
Retina (Philadelphia, Pa.)|January 21, 2017
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMABRobert L Avery, Alessandro A Castellarin, Nathan C Steinle, et al.
Ophthalmology|May 28, 2013
Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trialsMaureen G Maguire, Ebenezer Daniel, Ankoor R Shah, et al.
Pageof 2